← Open Payments lookup

KARLA OW: Open Payments

NPI 1841614492 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$992 in 12 payments from 8 companies in 2025. Trend: 2023 $319 · 2024 $546 · 2025 $992

Food & beverage: $914Education: $78
CompanyPaymentsAmount
Janssen Biotech, Inc.3$234
Merck Sharp & Dohme LLC2$215
Daiichi Sankyo Inc.1$141
Regeneron Healthcare Solutions, Inc.1$122
Gilead Sciences, Inc.1$112
Immunocore Limited1$91
Celgene Corporation2$48
Legend Biotech USA Inc.1$28

Products named: KEYTRUDA, CARVYKTI, DATROWAY, LIBTAYO, Trodelvy, KIMMTRAK, DARZALEX, REBLOZYL.

Industry payments across TX — which companies pay providers there.